Opportunity Information: Apply for CDC RFA GH13 1322
Apply for CDC RFA GH13 1322
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Provision of Comprehensive Care and Treatment Programs by Local Indigenous Entities in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 13, 2013 and posted on Feb 28, 2013.
- Applicants must submit their applications by Apr 16, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $50,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $10,000,000.00 in funding.
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- ELIGIBILITY INFORMATION Eligible Applicants Eligible applicants that can apply for this funding opportunity are listed below Local indigenous institutions of higher education Local indigenous not for profit organizations Local indigenous regional organizations Local indigenous parastatal organizations Local indigenous hospitals Eligible Agencies of the local and union government Local indigenous faith based and community based organizations Consortiums whose memberships consists only of any of the above local indigenous applicants Other Special Eligibility Criteria o At the time of submission the organizations must provide documentation proving success in comprehensive HIV prevention, care, and antiretroviral treatment (ART) programs. o The organizations must have an active comprehensive HIV prevention, care, and antiretroviral treatment (ART) program in place at time of submission. A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC funding opportunity (CDC RFA GH13-1322) called "Provision of Comprehensive Care and Treatment Programs by Local Indigenous Entities in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a large PEPFAR-supported cooperative agreement designed to expand and strengthen comprehensive HIV services in Tanzania by shifting more implementation responsibility to capable local Tanzanian organizations. The central idea is not only to deliver more services, but to build durable local capacity so that Tanzanian partners can manage, scale, and sustain high-quality HIV prevention, care, and treatment programs with broad coverage and stronger performance across the care continuum.
Programmatically, the grant focuses on improving HIV treatment outcomes and system performance, with specific targets set for 2018. A major emphasis is increasing the share of adults and children who remain alive and on antiretroviral therapy (ART) 12 months after starting treatment, moving from 67 percent to 85 percent, which signals a strong push toward better initiation, follow-up, and long-term treatment support. Closely related to that is a retention objective: raising overall retention of HIV-positive patients in care and treatment from 67 percent to 85 percent through improvements such as adherence counseling, better linkages and referrals between services, and stronger patient tracking approaches that reduce loss to follow-up.
The opportunity also prioritizes prevention of mother-to-child transmission (PMTCT) by dramatically increasing the percentage of HIV-positive pregnant women initiated on ART, from 14 percent to 98 percent, tied to implementation of "Option B" (a treatment approach that expands ART use for pregnant women to prevent transmission and improve maternal health). In addition, it includes an integrated TB/HIV objective: increasing the percentage of TB/HIV co-infected individuals who are tested and treated with antiretrovirals from 40 percent to 90 percent, reflecting full adoption of WHO 2010 treatment guidelines and a stronger standard of integrated care for people facing both diseases. Another key performance goal is improving linkage to care: increasing the proportion of people with confirmed positive HIV test results who are successfully connected from testing and counseling sites into care and treatment services, from 60 percent to 80 percent, which highlights the importance of referral systems, navigation, and timely enrollment.
Beyond clinical service delivery, the grant is explicitly about strengthening local health governance and management capacity. By 2018, District and Regional Health Management Teams are expected to show improved ability to plan, implement, and manage HIV programs. The announcement frames this in practical, measurable terms: the capacity to lead 100 percent of quarterly partner coordination meetings and the ability to increase annual Government of the United Republic of Tanzania budgets in a way that allows absorption of 25 PEPFAR-supported staff. In other words, the program is meant to push coordination and ownership downward into regional and district structures while also improving long-term sustainability by transitioning staffing costs into domestic budgets.
From a funding and administrative standpoint, this is a discretionary health funding opportunity using a cooperative agreement mechanism, meaning CDC would likely be substantially involved in program collaboration, technical guidance, and oversight compared with a more hands-off grant. The estimated total funding is $50,000,000, with an expected five awards. Individual awards are projected to range from $2,000,000 (floor) to $10,000,000 (ceiling). There is no cost-sharing or matching requirement noted. The CFDA number listed is 93.067 (Global AIDS), aligning it directly with U.S. global HIV/AIDS assistance.
Eligibility is intentionally limited to local indigenous entities in Tanzania, reinforcing the local capacity-building purpose. Eligible applicants include local indigenous institutions of higher education, local indigenous nonprofit organizations, regional organizations, parastatal organizations, hospitals, eligible agencies of local and union government, and local indigenous faith-based and community-based organizations. Consortium applications are allowed only if all members are within those local indigenous categories. The opportunity also sets additional eligibility conditions that effectively require applicants to already be proven HIV implementers: at submission, organizations must document prior success in comprehensive HIV prevention, care, and ART programs, and they must have an active comprehensive HIV prevention, care, and ART program in place at the time of application. If applying as a bona fide agent on behalf of a state or local government, applicants must provide a legal, binding agreement confirming that status.
Key dates in the notice reflect a 2013 competition cycle, with posting on February 28, 2013, an original closing date of April 9, 2013, an extended closing date of April 16, 2013, and an archive date of May 9, 2013. For support accessing the full announcement, the listed CDC contact point is the Procurement and Grants Office Technical Information Management Section (TIMS) via pgotiml@cdc.gov or pgotim@cdc.gov, and by phone at 770-488-2700.
FAQs: CDC RFA GH13-1322 (PEPFAR Tanzania) - Provision of Comprehensive Care and Treatment Programs by Local Indigenous Entities
What is CDC RFA GH13-1322?
CDC RFA GH13-1322 is a CDC funding opportunity titled "Provision of Comprehensive Care and Treatment Programs by Local Indigenous Entities in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)." It supports expansion and strengthening of comprehensive HIV services in Tanzania, with an explicit focus on shifting implementation responsibility to capable local Tanzanian organizations and building durable local capacity.
What is the overall purpose of this opportunity?
The purpose is twofold: (1) deliver and strengthen comprehensive HIV prevention, care, and treatment services with broad coverage and improved performance across the care continuum, and (2) build sustainable local capacity so Tanzanian partners can manage, scale, and sustain high-quality HIV programs over time.
What funding mechanism is used?
The opportunity uses a cooperative agreement mechanism. This implies CDC would likely have substantial involvement in collaboration, technical guidance, and oversight compared with a more hands-off grant mechanism.
How much funding is available in total?
The estimated total funding is $50,000,000.
How many awards are expected?
CDC expected to make five awards under this opportunity.
What is the expected award size (minimum and maximum)?
Individual awards are projected to range from $2,000,000 (floor) to $10,000,000 (ceiling).
Is cost sharing or matching required?
No cost-sharing or matching requirement is noted in the provided information.
What CFDA number is associated with this opportunity?
The CFDA number listed is 93.067 (Global AIDS).
Who is eligible to apply?
Eligibility is limited to local indigenous entities in Tanzania. Eligible applicants include local indigenous institutions of higher education, local indigenous nonprofit organizations, regional organizations, parastatal organizations, hospitals, eligible agencies of local and union government, and local indigenous faith-based and community-based organizations.
Are consortium applications allowed?
Yes, consortium applications are allowed only if all consortium members fall within the eligible local indigenous categories described in the opportunity.
Are there additional eligibility conditions beyond being a local indigenous entity?
Yes. At submission, organizations must document prior success in comprehensive HIV prevention, care, and ART programs, and must have an active comprehensive HIV prevention, care, and ART program in place at the time of application.
What is required if applying as a bona fide agent for a state or local government?
If applying as a bona fide agent on behalf of a state or local government, the applicant must provide a legal, binding agreement confirming that status.
What program areas does the grant emphasize?
The grant emphasizes comprehensive HIV services, including improvements in HIV treatment outcomes, retention in care, prevention of mother-to-child transmission (PMTCT) through ART initiation for pregnant women, integrated TB/HIV services, and stronger linkage from HIV testing to care and treatment.
What is the target for 12-month ART survival and continuation?
By 2018, the program aims to increase the share of adults and children who remain alive and on antiretroviral therapy (ART) 12 months after starting treatment from 67 percent to 85 percent.
What is the target for retention of HIV-positive patients in care and treatment?
By 2018, the program aims to raise overall retention of HIV-positive patients in care and treatment from 67 percent to 85 percent, supported by improvements such as adherence counseling, stronger linkages and referrals, and better patient tracking to reduce loss to follow-up.
What is the PMTCT target for ART initiation among HIV-positive pregnant women?
The opportunity prioritizes PMTCT by increasing the percentage of HIV-positive pregnant women initiated on ART from 14 percent to 98 percent, linked to implementation of "Option B."
What is "Option B" in this announcement?
Within the provided description, "Option B" refers to a treatment approach that expands ART use for pregnant women to prevent mother-to-child transmission and improve maternal health.
What is the TB/HIV integration target?
By 2018, the program aims to increase the percentage of TB/HIV co-infected individuals who are tested and treated with antiretrovirals from 40 percent to 90 percent, reflecting adoption of WHO 2010 treatment guidelines and stronger integrated care.
What is the linkage-to-care target from testing to treatment services?
The opportunity aims to increase the proportion of people with confirmed positive HIV test results who are successfully connected from testing and counseling sites into care and treatment services from 60 percent to 80 percent.
Does the opportunity address health system governance and management?
Yes. Beyond clinical service delivery, the program explicitly focuses on strengthening local health governance and management capacity, particularly at district and regional levels.
What are the 2018 expectations for District and Regional Health Management Teams?
By 2018, District and Regional Health Management Teams are expected to show improved ability to plan, implement, and manage HIV programs, including the capacity to lead 100 percent of quarterly partner coordination meetings.
What sustainability and domestic financing expectation is described?
The announcement describes an expectation that annual Government of the United Republic of Tanzania budgets increase in a way that allows absorption of 25 PEPFAR-supported staff, supporting a transition toward longer-term sustainability.
When was this funding opportunity posted and when did it close?
The notice reflects a 2013 competition cycle. It was posted on February 28, 2013. The original closing date was April 9, 2013, and the closing date was extended to April 16, 2013.
When was the opportunity archived?
The archive date listed is May 9, 2013.
Who can be contacted for help accessing the full announcement?
The listed CDC contact point is the Procurement and Grants Office Technical Information Management Section (TIMS). Email contacts are pgotiml@cdc.gov and pgotim@cdc.gov, and the phone number is 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: Strengthening Human Resources for Health through Public Health Training Improvements at the Muhimbili University of Health and Allied Sciences (MUHAS), School of Public Health and Social Sciences (SPHSS) in the United Republic of Tanzania under PEPFA
Previous opportunity: Increase Access to Comprehensive HIV/AIDS Prevention Care and Treatment Services in the Democratic Republic of Congo under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 1322
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 1322) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Human Resources for Health through Public Health Training Improvements at the Muhimbili University of Health and Allied Sciences (MUHAS), School of Public Health and Social Sciences (SPHSS) in the United Republic of Tanzania under PEPFA Apply for CDC RFA GH13 1323 Funding Number: CDC RFA GH13 1323 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Technical Assistance for Strengthening of Blood Transfusion Services and Increasing Access to Safe Blood in India under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1360 Funding Number: CDC RFA GH13 1360 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Supporting the implementation and capacity building of HIV/AIDS prevention interventions for youth using evidence based approaches in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1341 Funding Number: CDC RFA GH13 1341 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,000,000 |
| Accelerating Progress Against TB in Kenya (APA K) Apply for RFA 615 13 000003 Funding Number: RFA 615 13 000003 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $40,000,000 |
| Genomes to Natural Products (U01) Apply for RFA GM 14 002 Funding Number: RFA GM 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $2,250,000 |
| Investigator Initiated Multi Site Clinical Trials (Collaborative R01) Apply for PAR 13 128 Funding Number: PAR 13 128 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimers Disease Research Centers (P50) Apply for RFA AG 13 019 Funding Number: RFA AG 13 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43) Apply for RFA AR 14 005 Funding Number: RFA AR 14 005 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Collaborations for Macromolecular Interactions in Cells (R01) Apply for RFA GM 14 004 Funding Number: RFA GM 14 004 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Research Networks for Macromolecular Interactions in Cells (U54) Apply for RFA GM 14 005 Funding Number: RFA GM 14 005 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIH Directors Biomedical Research Workforce Innovation Award Broadening Experiences in Scientific Training (BEST) (DP7) Apply for RFA RM 12 022 Funding Number: RFA RM 12 022 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NGO Health Service Delivery Program Apply for RFA 442 13 000001 Funding Number: RFA 442 13 000001 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $6,600,000 |
| Advancing Eating Disorders Research through Dimensional Studies of Biology and Behavior (R01) Apply for RFA MH 14 030 Funding Number: RFA MH 14 030 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01) Apply for PAR 13 133 Funding Number: PAR 13 133 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| HIV Prevention with Key Populations Mali Apply for RFA 688 13 000004 Funding Number: RFA 688 13 000004 Agency: Mali USAID Bamako Category: Health Funding Amount: $2,000,000 |
| Supporting a Caribbean Regional Educational Institution to Deliver Leadership and Management Training to Health Professionals in Eleven Caribbean Partnership Framework Countries under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1348 Funding Number: CDC RFA GH13 1348 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Preclinical Innovation Program (PIP) (R01) Apply for RFA AI 13 008 Funding Number: RFA AI 13 008 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Mechanisms of Cellular Immunity in the Female Reproductive Tract (R01) Apply for RFA AI 12 054 Funding Number: RFA AI 12 054 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Planning Grants for the NIH National Research Mentoring Network (NRMN) (P20) Apply for RFA RM 13 002 Funding Number: RFA RM 13 002 Agency: National Institutes of Health Category: Health Funding Amount: $130,000 |
| Planning Grants for the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (P20) Apply for RFA RM 13 001 Funding Number: RFA RM 13 001 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 1322", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.